<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="59273">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02334358</url>
  </required_header>
  <id_info>
    <org_study_id>LG-HAOS004</org_study_id>
    <nct_id>NCT02334358</nct_id>
  </id_info>
  <brief_title>Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s</brief_title>
  <official_title>A Multi-center, Prospective and Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Injected Into the Nasolabial Folds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LG Life Sciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LG Life Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate long-term safety of YVOIRE classic s by incidence of adverse events including
      injection site local reactions and biodegradability
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>Until subject reaching total biodegradation criterion (WSRS change) ; an expected average of 2 years.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Wrinkle Severity Rating Scale (WSRS) change from baseline</measure>
    <time_frame>Until subject reaching total biodegradation criterion (WSRS change) ; an expected average of 2 years.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Normal; Healthy Adults With Extreme, Severe, Modreate, or Light Nasolabial Folds</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>YVOIRE Classic s</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subject who receive hyaluronic acid filler into the nasolabial folds
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age is over 18 years old

          -  Must be willing and able to provide written informed consent

        Exclusion Criteria:

          -  Sensitive to hyaluronic acid or any excipients of study product

          -  Have history of streptococcal disease, severe allergy or anaphylaxis or bleeding
             disorders.

          -  Women in pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Q Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <lastchanged_date>September 9, 2015</lastchanged_date>
  <firstreceived_date>January 4, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
